Barthelemy E, Chauvel C, Lemaire P, Boissel N, Chat L, Clappier E, De Marcellus V, Dhédin N, Di Lucia A, Duchmann M, Jestin M, Mathis S, Rabian F, Vasseur L, Duployez N, Chevillon F. Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation. Haematologica; https://doi.org/10.3324/haematol.2026.301758 [Early view].